|
5B0U
Crystal structure of the mutated 19 kDa protein of Oplophorus luciferase (nanoKAZ)
Deposited 2015-11-04
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K,I90V, P115E, Q124K, Y138I, N166R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;1.1 M di-ammonium tartrate
|
Resolution 1.71 Å
R-free 0.226
|
|
5B0U
Crystal structure of the mutated 19 kDa protein of Oplophorus luciferase (nanoKAZ)
Deposited 2015-11-04
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K,I90V, P115E, Q124K, Y138I, N166R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;1.1 M di-ammonium tartrate
|
Resolution 1.71 Å
R-free 0.226
|
|
5IBO
1.95A resolution structure of NanoLuc luciferase
Deposited 2016-02-22
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
Fragment:Full Length
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
DKA DECANOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20% (w/v) PEG 3350, 200 mM ammonium nitrate
|
Resolution 1.95 Å
R-free 0.250
|
|
5IBO
1.95A resolution structure of NanoLuc luciferase
Deposited 2016-02-22
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
Fragment:Full Length
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
DKA DECANOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;20% (w/v) PEG 3350, 200 mM ammonium nitrate
|
Resolution 1.95 Å
R-free 0.250
|
|
7SNR
2.00A Resolution Structure of NanoLuc Luciferase
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACT ACETATE ION × 2
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;1.0 M ammonium citrate dibasic, 0.1 M sodium acetate trihydrate
|
Resolution 2.00 Å
R-free 0.213
|
|
7SNR
2.00A Resolution Structure of NanoLuc Luciferase
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;291 K;1.0 M ammonium citrate dibasic, 0.1 M sodium acetate trihydrate
|
Resolution 2.00 Å
R-free 0.213
|
|
7SNS
1.55A Resolution Structure of NanoLuc Luciferase
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
ACT ACETATE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
|
Resolution 1.55 Å
R-free 0.189
|
|
7SNS
1.55A Resolution Structure of NanoLuc Luciferase
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
ACT ACETATE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
|
Resolution 1.55 Å
R-free 0.189
|
|
7SNS
1.55A Resolution Structure of NanoLuc Luciferase
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
ACT ACETATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
|
Resolution 1.55 Å
R-free 0.189
|
|
7SNS
1.55A Resolution Structure of NanoLuc Luciferase
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
ACT ACETATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.8 M Sodium acetate trihydrate, 0.1 M BIS-TRIS propane
|
Resolution 1.55 Å
R-free 0.189
|
|
7SNT
2.20A Resolution Structure of NanoLuc Luciferase with Bound Substrate Analog 3-methoxy-furimazine
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
9Z5 (4S)-8-benzyl-2-[(furan-2-yl)methyl]-3-methoxy-6-phenylimidazo[1,2-a]pyrazine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.0 M sodium citrate dibasic, 0.1 M Tris, 0.2 M NaCl
|
Resolution 2.20 Å
R-free 0.264
|
|
7SNT
2.20A Resolution Structure of NanoLuc Luciferase with Bound Substrate Analog 3-methoxy-furimazine
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.0 M sodium citrate dibasic, 0.1 M Tris, 0.2 M NaCl
|
Resolution 2.20 Å
R-free 0.264
|
|
7SNW
1.80A Resolution Structure of NanoLuc Luciferase with Bound Inhibitor PC 16026576
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 3
9YR 2-(methoxycarbonyl)thiophene-3-sulfonic acid × 1
9Y4 N-[(4-methylphenyl)methyl]-N~2~-phenylglycinamide × 1
GOL GLYCEROL × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.8 M Magnesium Sulfate, 0.1 M Bis-Tris Propane
|
Resolution 1.80 Å
R-free 0.175
|
|
7SNW
1.80A Resolution Structure of NanoLuc Luciferase with Bound Inhibitor PC 16026576
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 1
9YR 2-(methoxycarbonyl)thiophene-3-sulfonic acid × 1
9Y4 N-[(4-methylphenyl)methyl]-N~2~-phenylglycinamide × 1
GOL GLYCEROL × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.8 M Magnesium Sulfate, 0.1 M Bis-Tris Propane
|
Resolution 1.80 Å
R-free 0.175
|
|
7SNW
1.80A Resolution Structure of NanoLuc Luciferase with Bound Inhibitor PC 16026576
Deposited 2021-10-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
28–196(169 aa)
|
Mutation:A4E, Q11R, Q18L, L27V, A33N, K43R, V44I, A54I, F68D, L72Q, M75K, I90V, P115E, Q124K, Y138I, N166R
|
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 1
9YR 2-(methoxycarbonyl)thiophene-3-sulfonic acid × 1
9Y4 N-[(4-methylphenyl)methyl]-N~2~-phenylglycinamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;1.8 M Magnesium Sulfate, 0.1 M Bis-Tris Propane
|
Resolution 1.80 Å
R-free 0.175
|
|
7SNX
1.70A Resolution Structure of NanoBiT Complementation Reporter Complex of LgBit and SmBiT Subunits
Deposited 2021-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
28–183(156 aa)
Fragment:M-1 to S157
Chain B
185–195(11 aa)
|
Mutation:;A4E, Q11E, G15A, Q18L, L27V, F31L, A33N, G35A, K43R, V44I, L46R, G51A, A54I, G67A, F68D, G71A, L72Q, M75E, I76V, I90V, H93P, I107L, D108N, P115E, Q124K, Y138I, N144T, L149M, G157S
;
Mutation:W161Y, C164F, N166E
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;291 K;1.5 M Na/K Phosphate, 4 (v/v) % 1,3-propanediol
|
Resolution 1.70 Å
R-free 0.178
|
|
7SNY
2.10A Resolution Structure of NanoBiT Complementation Reporter Large Subunit LgBiT
Deposited 2021-10-28
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–183(156 aa)
Fragment:M-1 to S157
|
Mutation:;A4E, Q11E, G15A, Q18L, L27V, F31L, A33N, G35A, K43R, V44I, L46R, G51A, A54I, G67A, F68D, G71A, L72Q, M75E, I76V, I90V, H93P, I107L, D108N, P115E, Q124K, Y138I, N144T, L149M, G157S
;
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;291 K;15% (v/v) 2-methyl-2,4-pentanediol, 0.1 M sodium acetate, 2% (w/v) PEG 4000
|
Resolution 2.10 Å
R-free 0.277
|
|
8AQH
NanoLuc-Y94A luciferase mutant
Deposited 2022-08-12
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
|
Mutation:Y94A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 2.80 Å
R-free 0.305
|
|
8AQH
NanoLuc-Y94A luciferase mutant
Deposited 2022-08-12
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
|
Mutation:Y94A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 2.80 Å
R-free 0.305
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
28–196(169 aa)
|
Not recorded
|
CEI N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
28–196(169 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
28–196(169 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
28–196(169 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
28–196(169 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain F
28–196(169 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
PG4 TETRAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain G
28–196(169 aa)
|
Not recorded
|
CEI N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN-2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8AQI
NanoLuc luciferase with bound coelenteramide in surface allosteric site
Deposited 2022-08-12
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain H
28–196(169 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4;293.15 K;MgCl2, KCl, Na acetate, PEG-400
|
Resolution 1.99 Å
R-free 0.207
|
|
8HCQ
Cryo-EM structure of endothelin1-bound ETAR-Gq complex
Deposited 2022-11-02
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
27–184(158 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
8HCX
Cryo-EM structure of Endothelin1-bound ETBR-Gq complex
Deposited 2022-11-03
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
27–184(158 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
8HNK
CXCR3-DNGi complex activated by CXCL11
Deposited 2022-12-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
27–184(158 aa)
|
Not recorded
|
CLR CHOLESTEROL × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
8HNL
CXCR3-DNGi complex activated by PS372424
Deposited 2022-12-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
27–184(158 aa)
|
Not recorded
|
CLR CHOLESTEROL × 2
4AI (3S)-N-[(2S)-5-carbamimidamido-1-(cyclohexylmethylamino)-1-oxidanylidene-pentan-2-yl]-2-(4-oxidanylidene-4-phenyl-butanoyl)-3,4-dihydro-1H-isoquinoline-3-carboxamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.98 Å
|
|
8HNM
CXCR3-DNGi complex activated by VUF11222
Deposited 2022-12-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
27–184(158 aa)
|
Not recorded
|
CLR CHOLESTEROL × 2
4IE [4-(2-bromophenyl)phenyl]methyl-[[(1R,5S)-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methyl]-dimethyl-azanium × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.94 Å
|
|
8JPN
Cryo-EM structure of succinate receptor bound to cis-epoxysuccinic acid coupling to Gi
Deposited 2023-06-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
28–184(157 aa)
|
Not recorded
|
U9S (2R,3S)-oxirane-2,3-dicarboxylic acid × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
8K2X
CXCR3-DNGi complex activated by CXCL10
Deposited 2023-07-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
27–184(158 aa)
|
Not recorded
|
CLR CHOLESTEROL × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9K07
Cryo-EM structure of the DSO-5a-bound human BRS3-Gq complex
Deposited 2024-10-15
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
28–183(156 aa)
|
Not recorded
|
A1EL6 [(1~{S})-1-[1,4-dimethoxy-8-nitroso-5-(oxidanylamino)naphthalen-2-yl]-2,2-dimethyl-but-3-enyl] furan-2-carboxylate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.83 Å
|
|
9LWP
Cryo-EM structure of the unliganded human BRS3-Gq complex
Deposited 2025-02-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
28–183(156 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.93 Å
|
|
9UPU
Cryo-EM strucutre of CXCR4 complexed with agonist SDV1a
Deposited 2025-04-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
32–183(152 aa)
|
Not recorded
|
CLR CHOLESTEROL × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
9UPV
Cryo-EM structure of CXCR4 complexed with agonist SDVX1
Deposited 2025-04-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain R
32–183(152 aa)
|
Not recorded
|
CLR CHOLESTEROL × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|